StonvexLoading…
StonvexStonvexStonvexCore line items from ENS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $3.62B | $3.58B | $3.71B | $3.36B |
Operating Income | $464.69M | $351.57M | $278.36M | $206.25M |
Net Income | $363.74M | $269.10M | $175.81M | $143.91M |
EPS (Diluted) | $8.99 | $6.50 | $4.25 | $3.36 |
Total Assets | $3.97B | $3.47B | $3.62B | $3.74B |
Total Liabilities | $2.05B | $1.71B | $2.01B | $2.24B |
Cash & Equivalents | $343.13M | $333.32M | $346.67M | $402.49M |
Free Cash Flow OCF − CapEx | $139.26M | $370.59M | $191.17M | $-139.63M |
Shares Outstanding | 39.19M | 40.27M | 40.90M | 40.99M |